跳至主要内容
临床试验/CTRI/2024/02/063321
CTRI/2024/02/063321尚未招募Unknown

Evaluation of emerging inflammatory biomarkers in T2DM subjects across BMI spectrum. - NI

MAHE Manipal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Cases: Newly diagnosed cases of T2DM within 5 years of diagnosis, not on insulin, without any secondary complications of diabetes mellitus, will be included in the study.
  • Controls: Healthy individuals coming for routine health check up will be evaluated and recruited as controls.

排除标准

  • Cases: Patients diagnosed with diabetes for a period of more than 5 years or patients with advanced micro and macrovascular complications of diabetes, or patients on insulin injections will be excluded from the study.
  • Controls: Patients diagnosed with diabetes, thyroid disorders, or any other chronic lifestyle diseases (except hypertension), patients with acute infective illness, and patients on drugs that might alter glucose homeostasis (such as corticosteroids), trauma patients, and pregnant women will be excluded from the study.

研究者

发起方
MAHE Manipal

相似试验

Inflammatory biomarkers in diabetes patients of... | 临床试验